KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Other Gross PP&E Adjustments (2016 - 2025)

Amgen has reported Other Gross PP&E Adjustments over the past 17 years, most recently at $18.9 billion for Q4 2025.

  • Quarterly results put Other Gross PP&E Adjustments at $18.9 billion for Q4 2025, up 12.46% from a year ago — trailing twelve months through Dec 2025 was $18.9 billion (up 12.46% YoY), and the annual figure for FY2025 was $18.9 billion, up 12.46%.
  • Other Gross PP&E Adjustments for Q4 2025 was $18.9 billion at Amgen, up from -$900.0 million in the prior quarter.
  • Over the last five years, Other Gross PP&E Adjustments for AMGN hit a ceiling of $18.9 billion in Q4 2025 and a floor of -$3.6 billion in Q1 2024.
  • Median Other Gross PP&E Adjustments over the past 5 years was -$1.2 billion (2021), compared with a mean of $2.1 billion.
  • Biggest five-year swings in Other Gross PP&E Adjustments: soared 69.6% in 2023 and later tumbled 71.43% in 2024.
  • Amgen's Other Gross PP&E Adjustments stood at $5.9 billion in 2021, then surged by 56.14% to $9.2 billion in 2022, then soared by 69.6% to $15.6 billion in 2023, then grew by 7.77% to $16.8 billion in 2024, then increased by 12.46% to $18.9 billion in 2025.
  • The last three reported values for Other Gross PP&E Adjustments were $18.9 billion (Q4 2025), -$900.0 million (Q3 2025), and -$2.0 billion (Q2 2025) per Business Quant data.